Table. 1 Virus shedding in piglets post-challenge
From: A self-amplifying mRNA vaccine expressing PRV gD induces robust immunity against virulent mutants
Group | Number of animals with nasal shedding | Duration (days) |
PRV saRNA gD-50 μg | 3/3 | 5–7 |
PRV saRNA gD-5 μg | 3/3 | 6 |
PRV saRNA gD-5 μg-Twice | 3/3 | 4–6 |
PRV LA 2017 | 3/3 | 4–7 |
PRV LA-A-Twice | 3/3 | 4–5 |
saRNA NC-50 μg-Twice | 3/3 | Dead or 10 |
